ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Cancer-associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD-1 inhibitors and antiangiogenic agents in hepatocellular carcinoma

Chen, Qiurui; Wang, Xuejia; Zheng, Yichen; Ye, Ting; Liu, Jing; Wang, Jin-Quan; Zhang, Wen-feng; Wu, Feng-Lin; Bo, Huaben; Shao, Hongwei; Zhang, Rongxin*; Shen, Han*广东药学院
Cancer2023-11-1DOI: 10.1002/cncr.34935
1被引7阅读
引用收藏
分享

摘要

BackgroundChronic inflammation is considered the most critical predisposing factor of hepatocellular carcinoma (HCC), with inflammatory cell heterogeneity, hepatic fibrosis accumulation, and abnormal vascular proliferation as prominent features of the HCC tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) play a key role in HCC TME remodeling. Therefore, the level of abundance of CAFs may significantly affect the prognosis and outcome in HCC patients. MethodsUnsupervised clustering was performed based on 39 genes related to CAFs in HCC identified by single-cell RNA sequencing data. Patients of bulk RNA were grouped into CAF low abundance cluster and high abundance clusters. Subsequently, prognosis, immune infiltration landscape, metabolism, and treatment response between the two clusters were investigated and validated by immunohistochemistry. ResultsPatients in the CAF high cluster had a higher level of inflammatory cell infiltration, a more significant immunosuppressive microenvironment, and a significantly worse prognosis than those in the low cluster. At the metabolic level, the CAF high cluster had lower levels of aerobic oxidation and higher angiogenic scores. Drug treatment response prediction indicated that the CAF high cluster could have a better response to PD-1 inhibitors and conventional chemotherapeutic agents for HCC such as anti-angiogenic drugs, whereas CAF low cluster may be more sensitive to transarterial chemoembolization treatment. ConclusionsThis study not only revealed the TME characteristics of HCC with the difference in CAF abundance but also further confirmed that the combination therapy of PD-1 inhibitors and anti-angiogenic drugs may be more valuable for patients with high CAF abundance.

学科与关键词

关键词
angiogenesiscancer-associated fibroblastcombination therapyhepatocellular carcinomaTACEtumor immune microenvironment
相关
加载中…
  • PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity
    Guo, Shuang; Wang, Xinyue; Zhou, Hanxiao; Gao, Yue; Wang, Peng; Zhi, Hui; Sun, Yue; Zhang, Yakun; Gan, Jing; Xiao, Yun*; Ning, Shangwei*Biomolecules, 2022, 12(9): 1226.被引 4
  • Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression
    Lin, Chenhong; Chen, Yeda; Zhang, Feng; Zhu, Peng; Yu, Liangliang; Chen, Wenbiao*Gut Pathogens, 2023, 15(1): 26.
  • Prognostic stratification based on HIF-1α signaling for evaluating hypoxia status and immune landscape in hepatocellular carcinoma
    Zhuang, Hongkai; Zhang, Zedan; Chen, Bo; Tang, Chenwei; Chen, Xinming; Tan, Wenliang; Yang, Lei; Xie, Zhiqin; Ma, Xiaowu; Wang, Qingbin; Wang, Bingkun; Shang, Changzhen*; Chen, Yajin*JOURNAL OF BIG DATA, 2023, 10(1): 70.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer
发表日期
2023-11-01
卷期
第 129 卷, 第 21 期
页码
3405-3416
DOI
10.1002/cncr.34935
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31300737, 22277013]; Natural Science Foundation of Guangdong Province [2018A030313114]; Characteristic Innovation Projects in Ordinary Colleges and Universities of Guangdong Province [2021KTSCX053]

作者

  • C

    Chen, Qiurui (第一作者)

    guangdong pharmaceut univ

  • W

    Wang, Xuejia

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • Z

    Zheng, Yichen

    guangdong pharmaceut univ

  • Y

    Ye, Ting

    guangdong pharmaceut univ

  • L

    Liu, Jing

    guangdong pharmaceut univ

  • W

    Wang, Jin-Quan

    guangdong pharmaceut univ

  • Z

    Zhang, Wen-feng

    guangdong pharmaceut univ

  • W

    Wu, Feng-Lin

    guangdong pharmaceut univ

  • B

    Bo, Huaben

    guangdong pharmaceut univ

  • S

    Shao, Hongwei

    guangdong pharmaceut univ

  • Z

    Zhang, Rongxin (通讯)

    guangdong pharmaceut univ

  • S

    Shen, Han (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417